{
    "clinical_study": {
        "@rank": "89075", 
        "arm_group": {
            "arm_group_label": "HiRes90K\u2122  Advantage Cochlear Implant", 
            "arm_group_type": "Experimental", 
            "description": "HiRes90K\u2122 Advantage implant with HiFocus\u2122 Mid-Scala electrode will be implanted in adults with a moderate level of hearing loss in the low frequencies and severe-to-profound hearing loss in the mid-to-high frequencies."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the feasibility of preserving low-frequency\n      acoustic hearing in adults with a moderate degree of hearing loss in the low frequencies and\n      severe-to-profound hearing loss in the mid-to-high frequencies who are implanted with the\n      HiRes\u2122 90K Advantage implant with HiFocus\u2122 Mid-Scala electrode."
        }, 
        "brief_title": "Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus\u2122 Mid-Scala Electrode", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hearing Loss", 
            "Deafness", 
            "Hearing Disorders", 
            "Ear Diseases", 
            "Otorhinolaryngologic Diseases"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Deafness", 
                "Hearing Loss", 
                "Ear Diseases", 
                "Otorhinolaryngologic Diseases", 
                "Hearing Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  No previous cochlear implant experience\n\n          -  18 years of age or older\n\n          -  Up to a moderate sensorineural hearing loss in the low-to-mid frequencies (pure tone\n             average \u2264 65 dB HL for 125, 250, 500, and 1000 Hz) and a severe-to-profound\n             sensorineural hearing loss in the high frequencies (pure tone average \u2265 70 dB HL for\n             2,000, 4,000, and 8,000 Hz) in the ear to be implanted\n\n          -  Aided monosyllabic word score of 10-50% in the ear to be implanted\n\n          -  Up to a moderate sensorineural hearing loss in the low-to-mid frequencies (pure tone\n             average \u2264 65 dB HL for 125, 250, 500, and 1000 Hz) and a severe-to-profound\n             sensorineural hearing loss in the high frequencies (pure tone average \u2265 70 dB HL for\n             2,000, 4,000, and 8,000 Hz) in the contralateral (non-implanted) ear\n\n          -  English language proficiency\n\n          -  Willingness to participate in all scheduled procedures outlined in the protocol\n\n        Exclusion Criteria:\n\n          -  Previous inner ear surgery\n\n          -  Cochlear malformation or obstruction that would preclude full insertion of electrode\n             array\n\n          -  Presence of additional disabilities that would prevent or interfere with\n             participation in the required study procedures\n\n          -  Medical or psychological conditions that contraindicate surgery or impact the ability\n             to manage an implanted device or the study-related procedures\n\n          -  Evidence of central auditory lesion or compromised auditory nerve"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "15", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01959152", 
            "org_study_id": "CR0513"
        }, 
        "intervention": {
            "arm_group_label": "HiRes90K\u2122  Advantage Cochlear Implant", 
            "intervention_name": "HiRes\u2122 90K Advantage implant with HiFocus\u2122 Mid-Scala electrode", 
            "intervention_type": "Device"
        }, 
        "intervention_browse": {
            "mesh_term": "Imidacloprid"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "Cochlear Implant", 
            "HiRes\u2122 90K Advantage implant", 
            "Cochlear Implantation", 
            "HiFocus\u2122 Mid-Scala electrode", 
            "Listening Benefits", 
            "Adults", 
            "Cochlear Implant Benefit", 
            "HiRes Fidelity 120\u2122", 
            "Electrical Stimulation"
        ], 
        "lastchanged_date": "May 21, 2014", 
        "location": [
            {
                "contact": {
                    "email": "jwhittingham@cheo.on.ca; jwhitt@uottawa.ca", 
                    "last_name": "JoAnne Whittingham, M.Sc.", 
                    "phone": "(613) 738-3907"
                }, 
                "facility": {
                    "address": {
                        "city": "Halifax", 
                        "country": "Canada", 
                        "state": "Nova Scotia", 
                        "zip": "B3H 2Y9"
                    }, 
                    "name": "Dalhousie University, Department of Surgery, Division of Otolaryngology"
                }, 
                "investigator": {
                    "last_name": "Manohar Bance, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Adrienne.Comeau-Grandy@nshsc.nshealth.ca", 
                    "last_name": "Adrienne Comeau-Grandy, M.Sc., Aud", 
                    "phone": "(902) 492-8241"
                }, 
                "facility": {
                    "address": {
                        "city": "Ottawa", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "K1Y 4E9"
                    }, 
                    "name": "The Ottawa Hospital, Parkdale Clinic, Audiology Department"
                }, 
                "investigator": {
                    "last_name": "David Schramm, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "leah.smith@sunnybrook.ca", 
                    "last_name": "Leah Smith, MA, CCRA", 
                    "phone": "(416) 480-6100", 
                    "phone_ext": "85392"
                }, 
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M4N 3M5"
                    }, 
                    "name": "Sunnybrook Health Sciences Centre, Department of Otolaryngology - Head and Neck Surgery"
                }, 
                "investigator": {
                    "last_name": "Vincent Lin, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "1", 
        "official_title": "Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus\u2122 Mid-Scala Electrode", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Unaided low-frequency acoustic hearing thresholds (under earphones) in the implanted ear one month after device activation will be compared to baseline (pre-implant) thresholds in the same ear for audiometric frequencies 125-1000Hz. Threshold changes from baseline will be calculated as:\nComplete preservation of hearing:  threshold shift \u2264 15 dB\nPartial preservation of hearing:  threshold shift \u2265 16 dB with measurable thresholds\nNo preservation of hearing:  no measurable thresholds at \u2264 80 dB HL", 
            "measure": "Low-frequency unaided acoustic hearing thresholds pre and post implantation with the HiFocus\u2122 Mid-Scala electrode array", 
            "safety_issue": "Yes", 
            "time_frame": "One month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01959152"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Word recognition scores in quiet in the implanted ear one month after device activation compared to pre-implant score with a hearing aid", 
            "measure": "Word recognition in quiet pre and post implantation with the HiFocus\u2122 Mid-Scala electrode array", 
            "safety_issue": "No", 
            "time_frame": "One month"
        }, 
        "source": "Advanced Bionics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Advanced Bionics", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}